During the past decade, Erciyes Uni ; Hematology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Erciyes Uni ; Hematology" are "Chronic Lymphocytic Leukemia" (1 trials), "Lymphoma, Large B-Cell, Diffuse" (1 trials), "Non-Hodgkin's Lymphoma" (1 trials) and "Relapsed or Refractory Follicular Lymphoma" (1 trials). Many other conditions were trialed in "Erciyes Uni ; Hematology" in a lesser frequency.

Most popular intervention types in "Erciyes Uni ; Hematology" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (2 trials), "Bendamustine" (1 trials), "CHOP" (1 trials), "Chemotherapy (Induction Period)" (1 trials) and "Chlorambucil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Erciyes Uni ; Hematology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Erciyes Uni ; Hematology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Erciyes Uni ; Hematology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Erciyes Uni ; Hematology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".